For research use only. Not for therapeutic Use.
Succinate/Succinate Receptor Antagonist 1(Cat No.:I042294)is a synthetic compound designed to inhibit the interaction between succinate, a key metabolite, and its receptor, known as succinate receptor 1 (SUCNR1). The activation of SUCNR1 plays a role in various physiological processes, including inflammation, metabolism, and immune responses. By blocking this receptor, the antagonist aims to reduce inflammatory responses and potentially modulate disease pathways associated with metabolic disorders, cardiovascular diseases, and certain cancers. Research suggests that targeting this pathway could offer therapeutic benefits in conditions where succinate signaling contributes to disease progression.
Catalog Number | I042294 |
CAS Number | 2361972-29-2 |
Synonyms | N-methyl-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide |
Molecular Formula | C17H15N3O |
Purity | ≥95% |
IUPAC Name | N-methyl-2-[4-(1,8-naphthyridin-2-yl)phenyl]acetamide |
InChI | InChI=1S/C17H15N3O/c1-18-16(21)11-12-4-6-13(7-5-12)15-9-8-14-3-2-10-19-17(14)20-15/h2-10H,11H2,1H3,(H,18,21) |
InChIKey | CNTLNLSLKYIFRS-UHFFFAOYSA-N |
SMILES | CNC(=O)CC1=CC=C(C=C1)C2=NC3=C(C=CC=N3)C=C2 |